Mingtong Xu
107 Yanjiang West Road
Guangzhou, 510000, China
Guangzhou, 510000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
Analysis of colour defects and microvascular abnormalities in dysthyroid optic neuropathy using optical coherence tomography angiography.
Journal: Photodiagnosis and photodynamic therapy
Published: September 19, 2025
Increased Serum Lipopolysaccharide Levels are Related to a Higher Prevalent Risk of Subclinical Hypothyroidism.
Journal: International journal of endocrinology
Published: April 01, 2025
Fotagliptin add-on therapy to metformin in patients with uncontrolled type 2 diabetes: A randomised, multicentre, double-blind, placebo-controlled, phase 3 trial.
Journal: Diabetes, obesity & metabolism
Published: February 25, 2025
Recaticimab Monotherapy for Nonfamilial Hypercholesterolemia and Mixed Hyperlipemia: The Phase 3 REMAIN-1 Randomized Trial.
Journal: Journal of the American College of Cardiology
Published: May 23, 2024
Dysthyroid optic neuropathy treated with tocilizumab.
Journal: Endocrinology, diabetes & metabolism case reports
Published: April 25, 2024
A comprehensive epigenetic network can influence the occurrence of thyroid-associated ophthalmopathy by affecting immune and inflammatory response.
Journal: Scientific reports
Published: January 16, 2024
The Counteracting Effects of Ang II and Ang-(1-7) on the Function andGrowth of Insulin-secreting NIT-1 Cells.
Journal: Current diabetes reviews
Published: August 08, 2023
Glucose Metabolism Indices and the Development of Chronic Kidney Disease: A Cohort Study of Middle-Aged and Elderly Chinese Persons.
Journal: International journal of endocrinology
Published: January 05, 2023
Ang II Controls the Expression of Mapkap1 by miR-375 and Affects the Function of Islet β Cells.
Journal: Endocrine, metabolic & immune disorders drug targets
Published: September 05, 2022
Last Updated: 09/26/2026